Glycaemic efficacy and safety of ertugliflozin in patients with type 2 diabetes and stage 3 chronic kidney disease: an analysis from VERTIS CV Meeting Abstract

Industry Collaboration International Collaboration

cited authors

  • Dagogo-Jack, S.; Pratley, R. E.; Cherney, D. Z. I.; Charbonnel, B.; McGuire, D. K.; Cosentino, F.; Shih, W. J.; Liu, J.; Frederich, R.; Mancuso, J. P.; Raji, A.; Gantz, I.

authors

Publication Date

  • September 1, 2021

webpage

published in

category

start page

  • 225

end page

  • 226

volume

  • 64

issue

  • SUPPL 1